-
1 Comment
Ildong Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 6.7% below its 200 day moving average.
From a valuation standpoint, the stock is 91.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.
Ildong Pharmaceutical Co., Ltd's total revenue rose by 13.9% to $139B since the same quarter in the previous year.
Its net income has increased by 7.9% to $-19B since the same quarter in the previous year.
Finally, its free cash flow grew by 167.5% to $2B since the same quarter in the previous year.
Based on the above factors, Ildong Pharmaceutical Co., Ltd gets an overall score of 4/5.
| CurrencyCode | KRW |
|---|---|
| ISIN | KR7249420001 |
| Exchange | KO |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| PE Ratio | None |
|---|---|
| Target Price | 50000 |
| Market Cap | 325B |
| Beta | 1.04 |
| Dividend Yield | None |
Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-histamine drugs, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, topical preparation, and urogenital system applications. It also provides raw material drugs; health foods and foods; cosmetics; medical devices for scar treatment; and other drugs for treating thick wounds, osteoarthritis, periarthritis of shoulder, and artificial tears, as well as feminine cleanser products. In addition, the company manages licenses and provides contract manufacturing services. It also exports its products to approximately 20 countries worldwide. Ildong Pharmaceutical Co., Ltd. a strategic collaboration with Evotec SE to accelerate the development of various Ildong's proprietary projects through access to Evotec's INDiGO platform. The company was founded in 1941 and is headquartered in Seoul, South Korea.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 249420.KO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
